Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
Go back to Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1112.21 +13.64 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 257.46 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 877,045 | |||||

